LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary… — JAMA (Journal of the American Medical Association)

JAMA (Journal of the American Medical Association)@JAMAupdates · 16.2K subscribers Open in TelegramOpen

LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction Research Summary
https://jamanetwork.com/journals/jama/fullarticle/2853273

This trial evaluated whether starting evolocumab before percutaneous coronary intervention improved low-density lipoprotein cholesterol target achievement and clinical outcomes after acute myocardial infarction.

t.me/JAMAupdates/6566